Search research articles
Contact Us
Filters
Showing results (151-160 of 259) with videos related to
Page
of 26
Sort By:
Cancer Cell
|
March 23, 2013
The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity
Jianfei Qi, Manisha Tripathi, Rajeev Mishra, et al.
Nature Communications
|
October 6, 2018
Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers
Yan Zhang, Dayong Zheng, Ting Zhou, et al.
European Urology Oncology
|
August 19, 2022
Erratum to "Phase 3 Randomized Controlled Trial of Androgen Deprivation Therapy with or Without Docetaxel in High-risk Biochemically Recurrent Prostate Cancer After Surgery (TAX3503)" [Eur Urol Oncol 2021;4:543-52]
Michael J Morris, Jose Mauricio Mota, Kristine Lacuna, et al.
European Urology Oncology
|
May 22, 2021
Phase 3 Randomized Controlled Trial of Androgen Deprivation Therapy with or Without Docetaxel in High-risk Biochemically Recurrent Prostate Cancer After Surgery (TAX3503)
Michael J Morris, Jose Mauricio Mota, Kristine Lacuna, et al.
European Urology Oncology
|
May 31, 2022
First-line Systemic Treatment of Recurrent Prostate Cancer After Primary or Salvage Local Therapy: A Systematic Review of the Literature
Adam B Weiner, Aisha L Siebert, Sarah E Fenton, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 25, 2024
USP11 promotes prostate cancer progression by up-regulating AR and c-Myc activity
Majid Pornour, Hee-Young Jeon, Hyunju Ryu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 15, 2022
DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer
Thi Khanh Le, Chaïma Cherif, Kenneth Omabe, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 12, 2025
DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer
Thi Khanh Le, Chaïma Cherif, Kenneth Omabe, et al.
Nucleic Acids Research
|
February 2, 2023
SMAD3 promotes expression and activity of the androgen receptor in prostate cancer
Hee-Young Jeon, Majid Pornour, Hyunju Ryu, et al.
The Prostate
|
September 8, 2007
Regulation of global gene expression in the bone marrow microenvironment by androgen: androgen ablation increases insulin-like growth factor binding protein-5 expression
Chang Xu, Lynn F Graf, Ladan Fazli, et al.
Page
of 26
Search research articles
Search
Showing results (151-160 of 259) with videos related to
Sort By:
Page
of 26
Cancer Cell
|
March 23, 2013
The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity
Jianfei Qi, Manisha Tripathi, Rajeev Mishra, et al.
Nature Communications
|
October 6, 2018
Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers
Yan Zhang, Dayong Zheng, Ting Zhou, et al.
European Urology Oncology
|
August 19, 2022
Erratum to "Phase 3 Randomized Controlled Trial of Androgen Deprivation Therapy with or Without Docetaxel in High-risk Biochemically Recurrent Prostate Cancer After Surgery (TAX3503)" [Eur Urol Oncol 2021;4:543-52]
Michael J Morris, Jose Mauricio Mota, Kristine Lacuna, et al.
European Urology Oncology
|
May 22, 2021
Phase 3 Randomized Controlled Trial of Androgen Deprivation Therapy with or Without Docetaxel in High-risk Biochemically Recurrent Prostate Cancer After Surgery (TAX3503)
Michael J Morris, Jose Mauricio Mota, Kristine Lacuna, et al.
European Urology Oncology
|
May 31, 2022
First-line Systemic Treatment of Recurrent Prostate Cancer After Primary or Salvage Local Therapy: A Systematic Review of the Literature
Adam B Weiner, Aisha L Siebert, Sarah E Fenton, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 25, 2024
USP11 promotes prostate cancer progression by up-regulating AR and c-Myc activity
Majid Pornour, Hee-Young Jeon, Hyunju Ryu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 15, 2022
DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer
Thi Khanh Le, Chaïma Cherif, Kenneth Omabe, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 12, 2025
DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer
Thi Khanh Le, Chaïma Cherif, Kenneth Omabe, et al.
Nucleic Acids Research
|
February 2, 2023
SMAD3 promotes expression and activity of the androgen receptor in prostate cancer
Hee-Young Jeon, Majid Pornour, Hyunju Ryu, et al.
The Prostate
|
September 8, 2007
Regulation of global gene expression in the bone marrow microenvironment by androgen: androgen ablation increases insulin-like growth factor binding protein-5 expression
Chang Xu, Lynn F Graf, Ladan Fazli, et al.
Page
of 26